Treatment Monitoring of Immunotherapy and Targeted Therapy Using

Adult Aged Aged, 80 and over Brain Neoplasms / diagnostic imaging Combined Modality Therapy Disease Progression Female Humans Immunotherapy Lung Neoplasms / pathology Male Melanoma / pathology Middle Aged Molecular Targeted Therapy Retrospective Studies Treatment Outcome Tyrosine / analogs & derivatives
checkpoint inhibitors pseudoprogression radionecrosis response assessment treatment-related changes

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
04 2021
Historique:
received: 27 04 2020
accepted: 30 07 2020
pubmed: 6 9 2020
medline: 12 5 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

We investigated the value of

Identifiants

DOI: 10.2967/jnumed.120.248278 PMID: 32887757 PMC: PMC8049362
pubmed: 32887757
pii: jnumed.120.248278
doi: 10.2967/jnumed.120.248278
pmc: PMC8049362
doi:

Substances chimiques

(18F)fluoroethyltyrosine 1326R5J1IA
Tyrosine 42HK56048U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

464-470

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Neuro Oncol. 2015 Sep;17(9):1188-98
pubmed: 26250565
Neuro Oncol. 2016 Oct;18(10):1462-4
pubmed: 27591333
J Neurooncol. 2010 Sep;99(2):217-25
pubmed: 20091333
PLoS One. 2016 Jun 08;11(6):e0157139
pubmed: 27276226
Neuro Oncol. 2020 Jan 11;22(1):17-30
pubmed: 31437274
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557
pubmed: 30519867
J Neurooncol. 2017 Jul;133(3):595-602
pubmed: 28500560
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
J Clin Oncol. 2018 Sep 10;36(26):2702-2709
pubmed: 30059262
Lancet Oncol. 2015 Jun;16(6):e270-8
pubmed: 26065612
Radiat Oncol. 2016 Oct 21;11(1):139
pubmed: 27769279
Lancet Oncol. 2018 May;19(5):672-681
pubmed: 29602646
Brain. 2005 Mar;128(Pt 3):678-87
pubmed: 15689365
PLoS One. 2015 Jul 13;10(7):e0132515
pubmed: 26167681
J Neurooncol. 2013 Jan;111(1):11-8
pubmed: 23086431
J Nucl Med. 2014 Jan;55(1):30-6
pubmed: 24167081
Lancet Oncol. 2015 Nov;16(15):e534-e542
pubmed: 26545842
Neuro Oncol. 2017 Feb 1;19(2):281-288
pubmed: 27471107
Neuro Oncol. 2019 May 6;21(5):585-595
pubmed: 30615138
Neuro Oncol. 2017 Feb 1;19(2):162-174
pubmed: 28391295
Nuklearmedizin. 2011;50(2):74-82
pubmed: 21286660
Neuro Oncol. 2016 Sep;18(9):1199-208
pubmed: 27106405
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):103-11
pubmed: 25182751
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Nucl Med. 2012 Jul;53(7):1048-57
pubmed: 22645298
Lancet Oncol. 2017 Jul;18(7):863-873
pubmed: 28592387
Neuroimage Clin. 2018 Aug 19;20:537-542
pubmed: 30175040
Front Oncol. 2018 Feb 22;8:18
pubmed: 29520339
Cancer Treat Rev. 2017 Feb;53:25-37
pubmed: 28056412
J Nucl Med. 2008 May;49(5):694-9
pubmed: 18413375
BMC Cancer. 2017 Nov 6;17(1):713
pubmed: 29110648
Appl Radiat Isot. 2002 Dec;57(6):853-6
pubmed: 12406628
Cancer Immunol Res. 2016 Mar;4(3):179-82
pubmed: 26701266
Clin Nucl Med. 2020 Feb;45(2):113-117
pubmed: 31876831
J Nucl Med. 2012 Sep;53(9):1367-74
pubmed: 22872742
Int J Mol Sci. 2018 Sep 07;19(9):
pubmed: 30205431
Nat Rev Neurol. 2017 May;13(5):279-289
pubmed: 28387340
Expert Rev Anticancer Ther. 2020 Jan;20(1):9-15
pubmed: 31842635
Neuro Oncol. 2015 Sep;17(9):1293-300
pubmed: 26008606
Nuklearmedizin. 2011;50(4):167-73
pubmed: 21789338
N Engl J Med. 2012 Nov;367(18):1694-703
pubmed: 23020132
N Engl J Med. 2018 Aug 23;379(8):722-730
pubmed: 30134131
Semin Ultrasound CT MR. 2010 Dec;31(6):496-505
pubmed: 21147377

Auteurs

Norbert Galldiks (N)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany norbert.galldiks@uk-koeln.de.
Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Diana S Y Abdulla (DSY)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Lung Cancer Group, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Matthias Scheffler (M)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Lung Cancer Group, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Fabian Wolpert (F)

Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.

Jan-Michael Werner (JM)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Martin Hüllner (M)

Department of Nuclear Medicine, University Hospital and University of Zurich, Zurich, Switzerland.

Gabriele Stoffels (G)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Viola Schweinsberg (V)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Max Schlaak (M)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Nicole Kreuzberg (N)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Jennifer Landsberg (J)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Dermatology, University Hospital Bonn, Bonn, Germany.

Philipp Lohmann (P)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Garry Ceccon (G)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Christian Baues (C)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Radiation Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Maike Trommer (M)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Radiation Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Eren Celik (E)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Maximilian I Ruge (MI)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Martin Kocher (M)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Simone Marnitz (S)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Radiation Oncology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Gereon R Fink (GR)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Jörg-Christian Tonn (JC)

Department of Neurosurgery, University Hospital LMU Munich, Munich, Germany; and.

Michael Weller (M)

Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.

Karl-Josef Langen (KJ)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
Department of Nuclear Medicine, RWTH University Hospital Aachen, Aachen, Germany.

Jürgen Wolf (J)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Lung Cancer Group, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Cornelia Mauch (C)

Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany.
Department of Dermatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs du cerveau › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Thérapeutique › Association thérapeutique › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Tumeurs de l'appareil respiratoire › Tumeurs du poumon › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Thérapie moléculaire ciblée › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Treatment Monitoring of Immunotherapy and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Acides aminés cycliques › Acides aminés aromatiques › Tyrosine › Treatment Monitoring of Immunotherapy and...